Education
About Us
Working with TipRanks
Follow Us
Amexdrug Corporation (AXRX)
OTHER OTC:AXRX
| Dec 17 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 10.43M |
| Gross Profit | $ 1.96M |
| Operating Income | $ 214.62K |
| EBITDA | $ 226.81K |
| Net Income | $ 111.36K |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 245.03K |
| Total Assets | $ 2.31M |
| Total Debt | $ 799.66K |
| Net Debt | $ 564.24K |
| Total Liabilities | $ 1.51M |
| Stockholders' Equity | $ 806.69K |
| Cash Flow | |
| Free Cash Flow | $ 27.49K |
| Operating Cash Flow | $ 27.49K |
| Investing Cash Flow | $ 0.00 |
| Financing Cash Flow | $ -10.63K |
Amexdrug Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.